Suppression of Fas-mediated apoptosis via steric shielding by filovirus glycoproteins

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 994-998

  Noyori, Osamu ^a   Nakayama, Eri ^a   Maruyama, Junki ^a   Yoshida, Reiko ^a   Takada, Ayato ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

Apoptosis; Fas; Filovirus; Glycoprotein; Steric shielding

Indexed keywords

FAS ANTIGEN; FAS LIGAND; VIRUS GLYCOPROTEIN;

APOPTOSIS; ARTICLE; CELL SURFACE; CELL VIABILITY; FEMALE; FILOVIRUS; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNE EVASION; LIPID RAFT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALIA; MARBURGVIRUS;

APOPTOSIS; FAS; FILOVIRUS; GLYCOPROTEIN; STERIC SHIELDING;

ANTIGENS, CD95; APOPTOSIS; EBOLAVIRUS; GLYCOPROTEINS; HELA CELLS; HUMANS; MARBURGVIRUS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84888833481     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.11.018     Document Type: Article

References (34)

1. Geisbert T.W., Daddario-DiCaprio K.M., Geisbert J.B., Young H.A., Formenty P., Fritz E.A., Larsen T., Hensley L.E. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J. Infect. Dis. 2007, 196(Suppl. 2):S372-381.
2. Daddario-DiCaprio K.M., Geisbert T.W., Geisbert J.B., Ströher U., Hensley L.E., Grolla A., Fritz E.A., Feldmann F., Feldmann H., Jones S.M. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J. Virol. 2006, 80:9659-9666.
3. Negredo A., Palacios G., Vázquez-Morón S., González F., Dopazo H., Molero F., Juste J., Quetglas J., Savji N., de la Cruz Martínez M., Herrera J.E., Pizarro M., Hutchison S.K., Echevarría J.E., Lipkin W.I., Tenorio A. Discovery of an ebolavirus-like filovirus in Europe. PLoS Pathog. 2011, 7:e1002304.
4. Kuhn J.H., Bao Y., Bavari S., Becker S., Bradfute S., Brister J.R., Bukreyev A.A., Chandran K., Davey R.A., Dolnik O., Dye J.M., Enterlein S., Hensley L.E., Honko A.N., Jahrling P.B., Johnson K.M., Kobinger G., Leroy E.M., Lever M.S., Mühlberger E., Netesov S.V., Olinger G.G., Palacios G., Patterson J.L., Paweska J.T., Pitt L., Radoshitzky S.R., Saphire E.O., Smither S.J., Swanepoel R., Towner J.S., van der Groen G., Volchkov V.E., Wahl-Jensen V., Warren T.K., Weidmann M., Nichol S.T. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch. Virol. 2013, 158:301-311.
5. Jeffers S.A., Sanders D.A., Sanchez A. Covalent modifications of the ebola virus glycoprotein. J. Virol. 2002, 76:12463-12472.
6. Volchkov V.E., Feldmann H., Volchkova V.A., Klenk H.D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 1998, 95:5762-5767.
7. Volchkov V.E., Volchkova V.A., Ströher U., Becker S., Dolnik O., Cieplik M., Garten W., Klenk H.D., Feldmann H. Proteolytic processing of Marburg virus glycoprotein. Virology 2000, 268:1-6.
8. Dube D., Brecher M.B., Delos S.E., Rose S.C., Park E.W., Schornberg K.L., Kuhn J.H., White J.M. The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J. Virol. 2009, 83:2883-2891.
9. Kuhn J.H., Radoshitzky S.R., Guth A.C., Warfield K.L., Li W., Vincent M.J., Towner J.S., Nichol S.T., Bavari S., Choe H., Aman M.J., Farzan M. Conserved receptor-binding domains of Lake Victoria Marburgvirus and Zaire ebolavirus bind a common receptor. J. Biol. Chem. 2006, 281:15951-15958.
10. Chan S.Y., Ma M.C., Goldsmith M.A. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Gen. Virol. 2000, 81:2155-2159.
11. Takada A., Watanabe S., Ito H., Okazaki K., Kida H., Kawaoka Y. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 2000, 278:20-26.
12. Yang Z.Y., Duckers H.J., Sullivan N.J., Sanchez A., Nabel E.G., Nabel G.J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 2000, 6:886-889.
13. Francica J.R., Varela-Rohena A., Medvec A., Plesa G., Riley J.L., Bates P. Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLoS Pathog. 2010, 6:e1001098.
14. Noyori O., Matsuno K., Kajihara M., Nakayama E., Igarashi M., Kuroda M., Isoda N., Yoshida R., Takada A. Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses. Virology 2013, 446:152-161.
15. Miyawaki T., Uehara T., Nibu R., Tsuji T., Yachie A., Yonehara S., Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 1992, 149:3753-3758.
16. Schattner E., Friedman S.M. Fas expression and apoptosis in human B cells. Immunol. Res. 1996, 15:246-257.
17. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A., Klebanoff S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 1996, 184:429-440.
18. Thorburn A. Death receptor-induced cell killing. Cell Signal. 2004, 16:139-144.
19. Hotchkiss R.S., Strasser A., McDunn J.E., Swanson P.E. Cell death. N Engl J Med 2009, 361:1570-1583.
20. Best S.M. Viral subversion of apoptotic enzymes: escape from death row. Annu. Rev. Microbiol. 2008, 62:171-192.
21. Baize S., Leroy E.M., Georges-Courbot M.C., Capron M., Lansoud-Soukate J., Debré P., Fisher-Hoch S.P., McCormick J.B., Georges A.J. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 1999, 5:423-426.
22. Wauquier N., Becquart P., Padilla C., Baize S., Leroy E.M. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl. Trop. Dis. 2010, 4:e837.
23. Reed D.S., Hensley L.E., Geisbert J.B., Jahrling P.B., Geisbert T.W. Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol. 2004, 17:390-400.
24. Rubins K.H., Hensley L.E., Wahl-Jensen V., Daddario DiCaprio K.M., Young H.A., Reed D.S., Jahrling P.B., Brown P.O., Relman D.A., Geisbert T.W. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol. 2007, 8:R174.
25. Olejnik J., Alonso J., Schmidt K.M., Yan Z., Wang W., Marzi A., Ebihara H., Yang J., Patterson J.L., Ryabchikova E., Mühlberger E. Ebola virus does not block apoptotic signaling pathways. J. Virol. 2013, 87:5384-5396.
26. J. Maruyama, H. Miyamoto, M. Kajihara, H. Ogawa, K. Maeda, Y. Sakoda, R. Yoshida, A. Takada, Characterization of the envelope glycoprotein of a novel filovirus, Lloviu virus, J. Virol., in press.
27. Takada A., Watanabe S., Okazaki K., Kida H., Kawaoka Y. Infectivity-enhancing antibodies to Ebola virus glycoprotein. J. Virol. 2001, 75:2324-2330.
28. Nakayama E., Tomabechi D., Matsuno K., Kishida N., Yoshida R., Feldmann H., Takada A. Antibody-dependent enhancement of Marburg virus infection. J. Infect. Dis. 2011, S978-985.
29. Takada A., Ebihara H., Feldmann H., Geisbert T.W., Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J. Infect. Dis. 2007, 196(Suppl. 2):S347-356.
30. Reynard O., Borowiak M., Volchkova V.A., Delpeut S., Mateo M., Volchkov V.E. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J. Virol. 2009, 83:9596-9601.
31. Bavari S., Bosio C.M., Wiegand E., Ruthel G., Will A.B., Geisbert T.W., Hevey M., Schmaljohn C., Schmaljohn A., Aman M.J. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 2002, 195:593-602.
32. Chakrabandhu K., Hérincs Z., Huault S., Dost B., Peng L., Conchonaud F., Marguet D., He H.T., Hueber A.O. Palmitoylation is required for efficient Fas cell death signaling. EMBO J. 2007, 26:209-220.
33. Volchkov V.E., Volchkova V.A., Muhlberger E., Kolesnikova L.V., Weik M., Dolnik O., Klenk H.D. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001, 291:1965-1969.
34. Alazard-Dany N., Volchkova V., Reynard O., Carbonnelle C., Dolnik O., Ottmann M., Khromykh A., Volchkov V.E. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J. Gen. Virol. 2006, 87:1247-1257.